+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Effects of viral strain, transgene position, and target cell type on replication kinetics, genomic stability, and transgene expression of replication-competent murine leukemia virus-based vectors



Effects of viral strain, transgene position, and target cell type on replication kinetics, genomic stability, and transgene expression of replication-competent murine leukemia virus-based vectors



Journal of Virology 81(13): 6973-6983



The limited efficiency of in vivo gene transfer by replication-deficient retroviral vectors remains an obstacle to achieving effective gene therapy for solid tumors. One approach to circumvent this problem is the use of replication-competent retroviral vectors. However, the application of such vectors is at a comparatively early stage and the effects which virus strain, transgene cassette position, and target cell can exert on vector spread kinetics, genomic stability, and transgene expression levels remain to be fully elucidated. Thus, in this study a panel of vectors allowing the investigation of different design features on an otherwise genetically identical background were analyzed with respect to these readout parameters in cultures of both murine and human cells and in preformed tumors in nude mice. The obtained data revealed that (i) Moloney murine leukemia virus (Mo-MLV)-based vectors spread with faster kinetics, drive higher levels of transgene expression, and are more stable than equivalent Akv-MLV-based vectors; (ii) vectors containing the transgene cassette directly downstream of the envelope gene are genomically more stable than those containing it within the 3'-long terminal repeat U3 region; and (iii) the genomic stability of both strains seems to be cell line dependent.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 015675408

Download citation: RISBibTeXText

PMID: 17442710

DOI: 10.1128/jvi.02470-06


Related references

Transgene stability for three replication-competent murine leukemia virus vectors. Gene 329: 61-69, 2004

Transgene expression facilitated by the v-src splice acceptor can impair replication kinetics and lead to genomic instability of Rous sarcoma virus-based vectors. Journal of Virology 82(3): 1610-1614, 2007

Adenovirus replication-competent vectors (KD1, KD3) complement the cytotoxicity and transgene expression from replication-defective vectors (Ad-GFP, Ad-Luc). Cancer Gene Therapy 9(8): 651-654, 2002

Recombinant adenoviral vectors turn on the type I interferon system without inhibition of transgene expression and viral replication. Molecular Therapy 14(1): 129-138, 2006

Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo. Cancer Research 61(7): 2983-2995, 2001

Expression of heterologous genes from an IRES translational cassette in replication competent murine leukemia virus vectors. Gene 239(2): 227-235, 1999

A replication-competent feline leukemia virus vector that stably transduces green fluorescent protein transgene. Proceedings of the American Association for Cancer Research Annual Meeting 42: 114, 2001

Tissue- and tumor-specific targeting of murine leukemia virus-based replication-competent retroviral vectors. Journal of Virology 80(14): 7070-7078, 2006

Functions of the 5' leader of murine leukemia virus genomic RNA in virion structure, viral replication and pathogenesis, and MLV-derived vectors. Biochimie 78(7): 632-638, 1996

Kinetics of propagation of B-tropic murine leukemia virus on Fv-1b cell lines: requirement for multiple cycles of cell replication for transformation and viral antigen expression by RadLV. Virology 63(2): 367-383, 1975

Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nature Medicine. 2(5): 545-550, 1996

Latency associated promoter transgene expression in the central nervous system after stereotaxic delivery of replication-defective HSV-1-based vectors. Gene Therapy 8(14): 1057-1071, 2001

Propagation kinetics of retrovirus transgene vector and replication-competent retrovirus in static and microcarrier cell culture systems using different medium exchange strategies. Enzyme and Microbial Technology 38(1-2): 229-236, 2006

Inserting a nuclear targeting signal into a replication-competent Moloney murine leukemia virus affects viral export and is not sufficient for cell cycle-independent infection. Journal of Virology 76(16): 8475-8484, 2002

Replication-competent simian immunodeficiency virus vectors for expression of cytokine genes Implications for live-attenuated viral vaccines. Journal of Medical Primatology 24(4): 183, 1995